| Closed |
SWOG-7983 |
Radiation Therapy in Combination with CCNU in Patients with Incompletely Resected Gliomas of the Brain, Grade I and II |
2/4/1980 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8890 (INT-0109) |
Radical Prostatectomy versus Radiation Therapy for Clinical Stage A2 and B Adenocarcinoma of the Prostate (N0,M0) |
4/1/1990 |
1/1/1992 |
1% |
|
|
| Closed |
SWOG-781 |
Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's |
2/14/1972 |
8/8/1978 |
|
|
Published
|
| Closed |
S1300 |
Rand Ph II of Crizotinib + Pem vs Pem in ALK+ NSCLC Pts Progressing Post Crizotinib |
8/1/2014 |
9/1/2016 |
1% |
|
|
| Closed |
S1115 |
Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo |
8/15/2012 |
5/15/2014 |
100% |
|
Published
|
| Closed |
S1712 |
Rando PhII Ruxolitinib + BCR-ABL TKIs in CML w/Molecular Disease |
7/20/2018 |
|
96% |
|
|
| Closed |
S1117 |
Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML |
3/1/2012 |
11/14/2014 |
100% |
|
Published
|
| Closed |
S1310 |
Rando PII GSK1120212 vs 5-FU/Leucovorin or Capecitabine for Refractory Advanced Biliary |
2/15/2014 |
5/15/2015 |
60% |
|
|
| Closed |
S1614 |
Rando Prophylactic Antiviral HBV |
2/21/2019 |
11/15/2022 |
1% |
|
|
| Closed |
SWOG-8203/04 |
Randomized Comparison of Adriamycin, Mitoxantrone, and Bisantrene in Patients with Metastatic Breast Cancer not Previously Exposed to Intercalating Chemotherapy |
12/23/1982 |
5/1/1986 |
|
|
Published
|
| Closed |
SWOG-8514 |
Randomized Comparison of Cisplatin + 5-Fluorouracil Versus CBDCA + 5-Fluorouracil Versus Methotrexate In Advanced Squamous Cell Carcinoma of the Head and Neck, Phase III |
1/3/1985 |
3/1/1989 |
|
|
Published
|
| Closed |
SWOG-8223/24/25 |
Randomized Comparison of Drug Therapy for Squamous Cell Cancer of the Head and Neck with Early Assessment of Phase II Agents |
9/17/1982 |
1/31/1983 |
|
|
|
| Open |
S1608 |
Randomized Ph II for Relapsed Refractory FL |
8/10/2017 |
|
81% |
|
|
| Closed |
S0904 |
Randomized Ph II Ovarian vandetanib + docetaxel |
3/15/2010 |
8/1/2011 |
99% |
|
Published
|
| Closed |
SWOG-9327 |
Randomized Phase II Pilot Study of Pentoxifylline (Trental®) and Placebo in Patients with Metastatic Malignancy and Anorexia/Cachexia Syndrome |
2/15/1996 |
12/15/1997 |
15% |
|
|
| Open |
S1922 |
Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma |
12/16/2019 |
|
36% |
|
|
| Open |
S2107 |
Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable… |
6/6/2022 |
|
83% |
|
|
| Closed |
S1106 |
Randomized Phase II Younger Patients Mantle Cell Lymphoma |
10/1/2011 |
6/26/2013 |
29% |
|
Published
|
| Closed |
SWOG-8795 (INT-0094) (EST-1888) |
Randomized Prospective Comparison of Bacillus Calmette-Guerin and Mitomycin-C Therapy and Prophylaxis in Superficial Transitional Cell Carcinoma of the Bladder with DNA Flow Cytometric Analysis |
12/1/1988 |
5/15/1992 |
65% |
|
Published
|
| Closed |
SWOG-9115 (EST-1192) (INT-0127) |
Randomized Study of Standard Chemotherapy vs. STAMP V with Autologous Stem Cell Infusion in Stage IV Poor Prognosis Breast Carcinoma, Phase III, a BMT Study (Intergroup) |
2/1/1992 |
1/1/1994 |
14% |
|
|
